The last few days have been a wild ride, from US President Trump launching his memecoin to his inauguration and recently claiming the Jupiter airdrop. Rumors are also circulating regarding a strategic cryptocurrency reserve in the United States, with Ripple (XRP) taking priority. Payments-based cryptocurrency XRP is consolidating – perhaps the calm before the storm.
Meanwhile, Cardano (ADA), hovering around $1 support, could be ready for its next leg, with a breakout above its all-time high in sight. At the same time, attention has focused on this new DeFi crypto, which experts say could be the best new crypto to invest in: DTX Exchange (DTX).
DTX Exchange (DTX): Ready for Huge Gains
DTX Exchange (DTX) is among the best cryptos to buy this cycle for several reasons, from its huge growth prospects to its strong fundamentals. As an emerging cryptocurrency, it has a lot of room to run, outpacing major crypto coins with large market caps like Ripple (XRP) and Cardano (ADA).
Moreover, its real-world application paints an optimistic picture. It is located at the convergence of DeFi and TradFi and its unique offering will be a hybrid trading platform. As a single platform for all trading needs, including cryptos, stocks, ETFs and forex, its adoption is imminent: a new DeFi project to watch.
With over $12.5 million raised in seed funding and over 300,000 wallet addresses, its community is growing at a rapid pace. A token costs only $0.16 in the eighth round of the ICO and a 45x increase in value is expected after its planned Tier 1 exchange listing in the first quarter.
Ripple (XRP) Gathers Steam for the Next Leap
Ripple (XRP), a popular payment-based cryptocurrency, was one of the biggest gainers this month. It recorded a 40% gain on the monthly chart, rising from $2.2 to a high of $3.39. However, there was a slight decline as it consolidated around $3.1.
But the coming days promise a rebound, supported by key indicators like the 20-VWMA and the 9-HMA. At the same time, analysts are issuing bold price predictions for XRP, suggesting it could be ready for its next step.
Steph_iscrypto, full of optimism, has $14 as his bullish target. DefendDark, another top analyst, has $4.55 and $5.85 next on its list, placing Ripple (XRP) among the best coins to invest in. However, for higher ROI, DTX could be a better alternative, given its projected 45x upside.
Cardano (ADA): one of the Altcoins to watch
After hovering around $1 support for days, Cardano (ADA) could be ready for a recovery. A breakout above the all-time high of $3.10 in 2021 is expected, making it a good crypto to buy at the current market price.
According to VellaCryptoX, Cardano (ADA) holding the $1.07 support could pave the way for a rally towards $1.50. Meanwhile, enthusiast and analyst ADA_ONEVETCOTI expects the altcoin to reach $3 by the end of February and $5 by April.
Despite its significant upside potential, savvy investors looking for huge gains are betting more on DTX Exchange (DTX). This is due to ADA’s limited upside potential as a large cap. On the other hand, DTX has enough room to function as a new cryptocurrency.
DTX Exchange (DTX): Will it outperform Ripple (XRP) and Cardano (ADA)?
Gearing up for its planned first-quarter launch, DTX Exchange (DTX) is a new altcoin to watch. A 45x increase in value is expected after its debut on major exchanges, potentially surpassing popular altcoins like Ripple (XRP) and Cardano (ADA). Additionally, as a unique hybrid trading platform, its adoption is imminent.
Find out more information about DTX Exchange (DTX) by visiting the links below:
Buy in presale
Visit the DTX website
Join the DTX community
The subject matter and content of this article are those of the author alone. FinanceFeeds assumes no legal responsibility for the content of this article and it does not reflect the views of FinanceFeeds or its editorial staff.
The information contained on this page does not constitute advice or a recommendation on any course of action and does not take into account your personal circumstances, financial situation or individual needs. We strongly recommend that you seek independent professional advice or conduct your own independent research before acting on any information contained herein.
